APA (7th ed.) Citation

EF, G., JC, Y., NJ, M., CB, M., C, W., Z, Z., . . . JT, Y. (2024). Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 42(1), 38. https://doi.org/10.1200/JCO.23.00753

Chicago Style (17th ed.) Citation

EF, Gillespie, et al. "Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 42, no. 1 (2024): 38. https://doi.org/10.1200/JCO.23.00753.

MLA (9th ed.) Citation

EF, Gillespie, et al. "Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 42, no. 1, 2024, p. 38, https://doi.org/10.1200/JCO.23.00753.